Live feed07:00:00·9dPRReleasevia QuantisnowAstraZeneca to showcase Phase III data in liver, breast and bladder cancers and potential first-in-class rare disease therapy at ASCO 2026ByQuantisnow·Wall Street's wire, on your screen.AZN· AstraZeneca PLCHealth Care
